Prosecution Insights
Last updated: October 02, 2026

Academia Sinica

Technology area: Biotechnology & Pharmaceuticals

16 pending office actions • 11 art units • 16 examiners • 0 of 16 (0%) have an AI response strategy ready • 29 patents granted in the last 365 days

Analysis

Academia Sinica maintains a significant presence in the Biotechnology & Pharmaceuticals technology area with 14 pending office actions. These matters are distributed across 14 distinct examiners, suggesting a broad and diverse examination process. The portfolio spans 9 distinct art units, which indicates that the company's research and development efforts cover a wide range of specialized sub-disciplines within the biotechnology sector. Practitioners can expect to interact with a variety of examination styles and art unit cultures given the breadth of 9 distinct art units involved in the current 14 pending office actions.

The busiest examiner for the portfolio is PARK, EVELYN GRACE, who is currently managing 1 busiest examiner pending office action. This number of pending actions for the busiest individual highlights the high degree of fragmentation across the 14 distinct examiners. This diversity requires a flexible prosecution strategy to accommodate the various procedural preferences encountered across the 9 different units. The 14 distinct examiners ensure that almost every case is subject to a unique individual review. Such a distributed environment requires a versatile approach to address the varying perspectives of the patent office staff across the Biotechnology & Pharmaceuticals field.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

16
Total Pending OAs
13
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
2
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Due ≤ 30 days (2)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

10
Hard (62%)
4
Medium (25%)
2
Easy (12%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other5 (31%)
§103 only3 (19%)
§112 only2 (12%)
Double-patenting + other1 (6%)
Multi-statute (no §101)5 (31%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

10
Life Sciences
62% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
6% of docket
0
Mechanical / Eng
0% of docket
5
Business / Other
31% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

160 h
Manual time on pending OAs
32 h
Time saved (low, 20%)
56 h
Time saved (mid, 35%)
1.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
PARK, EVELYN GRACE 1 51.6% +40.5%
CHATTERJEE, JAYANTA 1 45.5% +80.0%
STOFFA, WYATT A 1 79.4% +22.8%
JOHNSON, KARA D 1 69.5% +24.6%
MOU, LIYUAN 1 42.9% +59.0%
HOWARD, ZACHARY C 1 64.0% +37.9%
KELLY-O'NEILL, YOLANDA LYNNETTE 1 33.3% +29.9%
PRIEST, JESSICA MARIE 1 — —
TURNER, FELICIA C 1 26.3% +30.1%
GONZALES, JOSEPHINE MARIA 1 26.6% +38.4%

Hard Cases (11)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17806932 METHOD AND BIOMARKER FOR DETECTION OR DIAGNOSIS OF MYOCARDIAL INFARCTION BROWN, MINDY G 13d
18286943 BOTANICAL SUPPLEMENT AND METHOD FOR PREVENTING DISEASES, PROMOTING GROWTH AND SURVIVAL OF AN ANIMAL BY USING THE SAME TURNER, FELICIA C 21d
18645166 METHOD FOR PROMOTING GROWTH OF PLANTS CHATTERJEE, JAYANTA 33d
18854965 Non-Invasive Blood Glucose Prediction by Deduction Learning System PARK, EVELYN GRACE —
18689852 COMPOUNDS AND THEIR USES FOR TREATING NEURODEGENERATIVE DISEASE MOU, LIYUAN —
18686862 METHODS OF TREATING NEURODEGENERATIVE DISEASES HOWARD, ZACHARY C —
18429813 CONVERSION OF BETA-HYDROXY CARBONYL SPECIES AND PREPARATION OF AMINO ALCOHOL PRECURSOR USING BIFUNCTIONAL CATALYSTS DERIVED FROM LAYERED DOUBLE HYDROXIDES KELLY-O'NEILL, YOLANDA LYNNETTE —
18572564 COMBINED CANCER THERAPY WITH AN EPITHELIAL CELL ADHESION MOLECULE (EPCAM) INHIBITOR AND A WNT INHIBITOR PRIEST, JESSICA MARIE —

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18286943 BOTANICAL SUPPLEMENT AND METHOD FOR PREVENTING DISEASES, PROMOTING GROWTH AND SURVIVAL OF AN ANIMAL BY USING THE SAME TURNER, FELICIA C 21d
18645166 METHOD FOR PROMOTING GROWTH OF PLANTS CHATTERJEE, JAYANTA 33d
18854965 Non-Invasive Blood Glucose Prediction by Deduction Learning System PARK, EVELYN GRACE —
18701598 HIGH RESOLUTION TIME-OF-FLIGHT MASS SPECTROMETER AND METHODS OF PRODUCING THE SAME STOFFA, WYATT A —
18697799 CELL CULTURE PLATFORMS, METHODS AND USES THEREOF JOHNSON, KARA D —
18689852 COMPOUNDS AND THEIR USES FOR TREATING NEURODEGENERATIVE DISEASE MOU, LIYUAN —
18686862 METHODS OF TREATING NEURODEGENERATIVE DISEASES HOWARD, ZACHARY C —
18429813 CONVERSION OF BETA-HYDROXY CARBONYL SPECIES AND PREPARATION OF AMINO ALCOHOL PRECURSOR USING BIFUNCTIONAL CATALYSTS DERIVED FROM LAYERED DOUBLE HYDROXIDES KELLY-O'NEILL, YOLANDA LYNNETTE —

Top Art Units

Art UnitApps
1662 1
2881 1
1628 1
1793 1
1631 1
1654 1
1625 1
1642 1
1732 1
1681 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18854965 Non-Invasive Blood Glucose Prediction by Deduction Learning System PARK, EVELYN GRACE — §101§102§112 Non-Final OA — Pending Oct 07, 2024
18645166 METHOD FOR PROMOTING GROWTH OF PLANTS CHATTERJEE, JAYANTA 1662 §103§112 Final Rejection 33d Pending Apr 24, 2024
18701598 HIGH RESOLUTION TIME-OF-FLIGHT MASS SPECTROMETER AND METHODS OF PRODUCING THE SAME STOFFA, WYATT A 2881 §112 Non-Final OA — Pending Apr 15, 2024
18697799 CELL CULTURE PLATFORMS, METHODS AND USES THEREOF JOHNSON, KARA D — §103§112DP Non-Final OA — Pending Apr 02, 2024
18689852 COMPOUNDS AND THEIR USES FOR TREATING NEURODEGENERATIVE DISEASE MOU, LIYUAN 1628 §103§112 Final Rejection — Pending Mar 06, 2024
18686862 METHODS OF TREATING NEURODEGENERATIVE DISEASES HOWARD, ZACHARY C — §102§112 Non-Final OA — Pending Feb 26, 2024
18429813 CONVERSION OF BETA-HYDROXY CARBONYL SPECIES AND PREPARATION OF AMINO ALCOHOL PRECURSOR USING BIFUNCTIONAL CATALYSTS DERIVED FROM LAYERED DOUBLE HYDROXIDES KELLY-O'NEILL, YOLANDA LYNNETTE — §103§112 Non-Final OA — Pending Feb 01, 2024
18572564 COMBINED CANCER THERAPY WITH AN EPITHELIAL CELL ADHESION MOLECULE (EPCAM) INHIBITOR AND A WNT INHIBITOR PRIEST, JESSICA MARIE — §103§112Other Non-Final OA — Pending Dec 20, 2023
18286943 BOTANICAL SUPPLEMENT AND METHOD FOR PREVENTING DISEASES, PROMOTING GROWTH AND SURVIVAL OF AN ANIMAL BY USING THE SAME TURNER, FELICIA C 1793 §103 Non-Final OA 21d Pending Oct 13, 2023
18267996 CELL CULTURE SYSTEMS, METHODS AND USES THEREOF GONZALES, JOSEPHINE MARIA 1631 §101§102§103§112DP Non-Final OA — Pending Jun 16, 2023
18266882 ANTAGONIST OF INTERLEUKIN-17B RECEPTOR (IL-17RB) AND USE THEREOF BRADLEY, CHRISTINA 1654 §101§102§112 Non-Final OA — Pending Jun 13, 2023
18116952 COMPOSITION AND METHOD FOR MODULATING FIBROBLAST GROWTH FACTOR RECEPTOR 3 ACTIVATION RZECZYCKI, PHILLIP MATTHEW 1625 §101§102 Final Rejection — Pending Mar 03, 2023
18010647 ANTIBODIES TO INTERLEUKIN-1BETA AND USES THEREOF LU, CHENG 1642 §112 Non-Final OA — Pending Dec 15, 2022
17946651 METAL OXIDES-SILICA COMPOSITE AND METHOD FOR PREPARING THE SAME PATEL, SMITA S 1732 §103 Non-Final OA — Pending Sep 16, 2022
17806932 METHOD AND BIOMARKER FOR DETECTION OR DIAGNOSIS OF MYOCARDIAL INFARCTION BROWN, MINDY G 1681 §101§112 Non-Final OA 13d Pending Jun 14, 2022
17630929 METHODS OF TREATING POMPE DISEASE CHONG, YONG SOO 1623 §103 Non-Final OA — Pending Jan 28, 2022

Managing Academia Sinica's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month